Physician profile
Brock Haskell
NPI 1821627746
$1,758.50
in general payments reported to CMS, 2019-2025
17 companies · $333 in 2025
The $333 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $586 · 2022: $449 · 2023: $115 · 2024: $276 · 2025: $333.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $724.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $723.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sunovion Pharmaceuticals INC. | $531.19 | 2021-2022 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $432.51 | 2021-2025 | Caplyta |
| Abbvie INC. | $284.52 | 2021-2025 | |
| Tris Pharma INC | $134.20 | 2022-2025 | Dyanavel Xr |
| Lundbeck LLC | $62.55 | 2021-2024 | Rexulti |
| Otsuka America Pharmaceutical, INC. | $62.06 | 2021 | |
| Janssen Pharmaceuticals, INC | $38.05 | 2021-2023 | Spravato |
| Supernus Pharmaceuticals, INC. | $34.69 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $30.23 | 2022-2023 | Austedo Xr |
| Neurocrine Biosciences, INC. | $21.58 | 2021 | |
| Ironshore Pharmaceuticals INC. | $21.47 | 2023 | Jornay Pm |
| Indivior INC. | $20.83 | 2023 | Perseris |
| Collegium Pharmaceutical, INC. | $20.16 | 2025 | Jornay Pm |
| Takeda Pharmaceuticals U.S.A., INC. | $19.59 | 2021 | |
| Vanda Pharmaceuticals INC. | $19.08 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axsome Therapeutics, INC. | $15.13 | 2023 | Auvelity |
| Corium, LLC | $10.66 | 2024 | Azstarys |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brock Haskell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.